Adaptation, Transformation and Resilience in Healthcare Comment on "Government Actions and Their Relation to Resilience in Healthcare During the COVID-19 Pandemic in New South Wales, Australia and Ontario, Canada".


Journal

International journal of health policy and management
ISSN: 2322-5939
Titre abrégé: Int J Health Policy Manag
Pays: Iran
ID NLM: 101619905

Informations de publication

Date de publication:
01 09 2022
Historique:
received: 21 12 2021
accepted: 09 02 2022
medline: 16 8 2023
pubmed: 7 3 2022
entrez: 6 3 2022
Statut: ppublish

Résumé

Adaptive capacity is a critical component of building resilience in healthcare (RiH). Adaptive capacity comprises the ability of a system to cope with and adapt to disturbances. However, "shocks," such as the current coronavirus disease 2019 (COVID-19) pandemic, can potentially exceed critical adaptation thresholds and lead to systemic collapse. To effectively manage healthcare systems during periods of crises, both adaptive and transformative changes are necessary. This commentary discusses adaptation and transformation as two complementary, integral components of resilience and applies them to healthcare. We treat resilience as an emergent property of complex systems that accounts for multiple, often disparately distinct regimes in which multiple processes (eg, adaptation, recovery) are subsumed and operate. We argue that Convergence Mental Health and other transdisciplinary paradigms such as Brain Capital and One Health can facilitate resilience planning and management in healthcare systems.

Identifiants

pubmed: 35247939
doi: 10.34172/ijhpm.2022.7043
pmc: PMC9808225
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

1949-1952

Commentaires et corrections

Type : CommentOn

Informations de copyright

© 2022 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Auteurs

David G Angeler (DG)

Swedish University of Agricultural Sciences, Department of Aquatic Sciences and Assessment, Uppsala, Sweden.
The PRODEO Institute, San Francisco, CA, USA.
IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC, Australia.

Harris A Eyre (HA)

IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC, Australia.
Global Brain Health Institute, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Trinity College Dublin, Dublin 2, Ireland.
Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.
The PRODEO Institute, San Francisco, CA, USA.
Neurosience-inspired Policy Initiative, Organisation for Economic Co-Operation and Development (OECD), Paris, France.
Meadows Mental Health Policy Institute, Dallas, TX, USA.

Michael Berk (M)

IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC, Australia.
Department of Psychiatry, University of Melbourne, Melbourne, VIC, Australia.
Orygen Youth Health, University of Melbourne, Melbourne, VIC, Australia.
The Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.

Craig R Allen (CR)

Center for Resilience in Agricultural Working Landscapes, School of Natural Resources, University of Nebraska - Lincoln, Lincoln, NE, USA.

William Hynes (W)

Neurosience-inspired Policy Initiative, Organisation for Economic Co-Operation and Development (OECD), Paris, France.

Igor Linkov (I)

US Army Engineer Research and Development Center, Concord, MA, USA.
Carnegie Mellon University, Pittsburgh, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH